Lv1
38 积分 2022-11-10 加入
Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk
1个月前
已完结
葡萄膜炎的流行病学
1个月前
已完结
Ziftomenib (KO-539): a potent and selective Menin inhibitor for the treatment of recurrent or refractory acute myeloid leukemia
2个月前
已关闭
Ziftomenib in relapsed or refractory acute myeloid leukaemia (KOMET-001): a multicentre, open-label, multi-cohort, phase 1 trial
3个月前
已完结
Menin inhibitors for adult acute myeloid leukemia: 2025 update
3个月前
已完结
Advances and challenges in the purification of recombinant coagulation factors: A review
7个月前
已完结
Demographics, clinical profile and treatment landscape of patients with haemophilia B in China
9个月前
已完结
皖公网安备34019202002308